Literature DB >> 24436533

Lung cancer ablation: complications.

Takao Hiraki1, Hideo Gobara1, Hiroyasu Fujiwara1, Hiroaki Ishii1, Koji Tomita1, Mayu Uka1, Satoko Makimoto1, Susumu Kanazawa1.   

Abstract

Although radiofrequency ablation for lung cancer is generally safe (with a mortality rate <1%), it may cause various complications. Common complications include pneumothorax, pleural effusion, and parenchymal hemorrhage. Although most complications can be treated conservatively or with minimal therapy, physicians should be aware of rare but serious complications. Potentially fatal complications include massive hemorrhage, intractable pneumothorax due to bronchopleural fistula, pulmonary artery pseudoaneurysm, systemic air embolism, and pneumonitis. Other serious complications include injury to the nearby tissues (e.g., brachial nerve plexus, phrenic nerve, diaphragm, and chest wall), needle tract seeding, lung abscess, empyema, and skin burn. Although cavitation of the ablation zone is usually insignificant clinically, such a cavity occasionally ruptures, leading to pneumothorax and bleeding. Cavities may also serve as a scaffold for fungal colonization. Precautions to minimize risk should be taken whenever possible. Nevertheless, serious complications may occur, and thus physicians should be aware of the appropriate treatments for these complications. This article reviews complications associated with lung cancer ablation.

Entities:  

Keywords:  complication; interventional radiology; lung cancer; radiofrequency ablation

Year:  2013        PMID: 24436533      PMCID: PMC3709965          DOI: 10.1055/s-0033-1342958

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  39 in total

1.  Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases.

Authors:  Takao Hiraki; Hideo Gobara; Hidefumi Mimura; Yoshifumi Sano; Shinichi Toyooka; Kentaro Shibamoto; Ryotaro Kishi; Mayu Uka; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2010-05-26       Impact factor: 3.464

2.  Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.

Authors:  T C Chua; A Sarkar; A Saxena; D Glenn; J Zhao; D L Morris
Journal:  Ann Oncol       Date:  2010-03-24       Impact factor: 32.976

3.  Massive hemoptysis from pulmonary artery pseudoaneurysm caused by lung radiofrequency ablation: successful treatment by coil embolization.

Authors:  Koichiro Yamakado; Haruyuki Takaki; Motoshi Takao; Shuichi Murashima; Hiroshi Kodama; Masataka Kashima; Atsuhiro Nakatsuka; Junji Uraki; Hideto Shimpo; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2009-05-05       Impact factor: 2.740

4.  Aspergilloma in a cavity formed after percutaneous radiofrequency ablation for lung cancer.

Authors:  Takao Hiraki; Hideo Gobara; Hidefumi Mimura; Yoshifumi Sano; Nagio Takigawa; Takehiro Tanaka; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2009-09-17       Impact factor: 3.464

5.  Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.

Authors:  Takuji Yamagami; Takeharu Kato; Tatsuya Hirota; Rika Yoshimatsu; Tomohiro Matsumoto; Tsunehiko Nishimura
Journal:  J Vasc Interv Radiol       Date:  2006-10       Impact factor: 3.464

6.  Bronchiolitis obliterans organizing pneumonia after radiofrequency ablation of lung cancer: report of three cases.

Authors:  Takao Hiraki; Hideo Gobara; Katsuya Kato; Shinichi Toyooka; Hidefumi Mimura; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2012-01       Impact factor: 3.464

7.  Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.

Authors:  Yusuke Matsui; Takao Hiraki; Hideo Gobara; Mayu Uka; Yoshihisa Masaoka; Akihiro Tada; Shinichi Toyooka; Toshiharu Mitsuhashi; Hidefumi Mimura; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2012-04-17       Impact factor: 3.464

8.  Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern.

Authors:  Nour-Eldin A Nour-Eldin; Nagy N N Naguib; Martin Mack; John E Abskharon; Thomas J Vogl
Journal:  Eur Radiol       Date:  2010-07-28       Impact factor: 5.315

9.  Air embolism during needle placement for CT-guided radiofrequency ablation of an unresectable metastatic lung lesion.

Authors:  Tomohisa Okuma; Toshiyuki Matsuoka; Shinichi Tutumi; Kenji Nakmura; Yuichi Inoue
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

10.  Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging.

Authors:  Akira Yamamoto; Toshiyuki Matsuoka; Masami Toyoshima; Tomohisa Okuma; Yoshimasa Oyama; Masao Hamuro; Keiko Nakayama; Kiyotoshi Inoue; Kenji Nakamura; Yuichi Inoue
Journal:  AJR Am J Roentgenol       Date:  2004-12       Impact factor: 3.959

View more
  23 in total

Review 1.  Common complications of nonvascular percutaneous thoracic interventions: diagnosis and management.

Authors:  Azzam Khankan; Shireen Sirhan; Fadi Aris
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 2.  Cryoablation of Lung Metastases: Review of Recent Literature and Ablation Technique.

Authors:  Patrick W Eiken; Brian T Welch
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 3.  Microwave Ablation in Primary Lung Malignancies.

Authors:  Amgad M Moussa; Etay Ziv; Stephen B Solomon; Juan C Camacho
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 4.  Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors.

Authors:  Arian Mansur; Tushar Garg; Apurva Shrigiriwar; Vahid Etezadi; Christos Georgiades; Peiman Habibollahi; Timothy C Huber; Juan C Camacho; Sherif G Nour; Alan Alper Sag; John David Prologo; Nariman Nezami
Journal:  Diagnostics (Basel)       Date:  2022-05-24

5.  Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702).

Authors:  Hideo Gobara; Yasuaki Arai; Takeshi Kobayashi; Koichiro Yamakado; Yoshitaka Inaba; Yoshihisa Kodama; Takuji Yamagami; Miyuki Sone; Hirokazu Watanabe; Yoshihiro Okumura; Takayoshi Shinya; Hiroaki Kurihara; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2016-06-03       Impact factor: 2.374

6.  Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non-small cell lung cancer.

Authors:  Sushant Kumar Das; Ya-Yong Huang; Bing Li; Xiao Xuan Yu; Ru Hui Xiao; Han Feng Yang
Journal:  Oncol Lett       Date:  2019-11-25       Impact factor: 2.967

7.  Artificial pneumothorax improves radiofrequency ablation of pulmonary metastases of hepatocellular carcinoma close to mediastinum.

Authors:  Taiyang Zuo; Wenli Lin; Fengyong Liu; Jinshun Xu
Journal:  BMC Cancer       Date:  2021-05-06       Impact factor: 4.430

8.  Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases.

Authors:  Joyce W Y Chan; Rainbow W H Lau; Jenny C L Ngai; Carita Tsoi; Cheuk Man Chu; Tony S K Mok; Calvin S H Ng
Journal:  Transl Lung Cancer Res       Date:  2021-04

9.  Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors.

Authors:  Xin Ye; Weijun Fan; Jun-Hui Chen; Wei-Jian Feng; Shan-Zhi Gu; Yue Han; Guang-Hui Huang; Guang-Yan Lei; Xiao-Guang Li; Yu-Liang Li; Zhen-Jia Li; Zheng-Yu Lin; Bao-Dong Liu; Ying Liu; Zhong-Min Peng; Hui Wang; Wu-Wei Yang; Xia Yang; Bo Zhai; Jun Zhang
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

10.  Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know.

Authors:  Shivank Bhatia; Keith Pereira; Prasoon Mohan; Govindarajan Narayanan; Medhi Wangpaichitr; Niramol Savaraj
Journal:  Indian J Radiol Imaging       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.